他汀类药物使用与增强CT静脉注射碘对比剂后对比剂相关急性肾损伤之间是否存在关联
该回顾性研究纳入12371例接受腹部盆腔增强CT静脉注射碘对比剂的患者,比较他汀使用者与非使用者对比剂相关急性肾损伤(CI-AKI)的发生率,结果显示他汀使用与CI-AKI风险无显著关联(p=0.342)。在亚组分析中,高强度他汀与低至中等强度他汀使用者的CI-AKI发生率亦无显著差异(p=0.355),按基线eGFR分层后结果一致。
要点
- 静脉注射碘对比剂增强CT后,他汀使用与CI-AKI风险无显著关联(p=0.342)。
- 高强度他汀与低至中等强度他汀使用者的CI-AKI发生率无显著差异(p=0.355)。
- 按基线eGFR分层后,高强度与低至中等强度他汀组间CI-AKI事件仍无显著差异。
核心结论
- 他汀使用与接受腹部盆腔增强CT静脉注射碘对比剂患者的CI-AKI事件风险无显著关联。
- 亚组分析中,高强度他汀与低至中等强度他汀相比,CI-AKI事件无显著差异。
研究设计与样本
- 回顾性研究,共纳入12371例接受腹部盆腔增强CT静脉注射碘对比剂的患者,分为他汀使用者与非使用者。
诊断标准与关键数值
- 他汀使用者与非使用者CI-AKI事件比较p=0.342。
- 高强度他汀与低至中等强度他汀使用者CI-AKI事件比较p=0.355。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Contrast-induced acute kidney injury (CI-AKI) is one of the leading causes of new-onset renal failure in hospitalized patients. Statin has been evaluated for its protective effect against CI-AKI but rarely in patients receiving intravenous (IV) administrations of iodine-based contrast media for enhanced computed tomography (CT).
METHODS: In total, 12,371 patients who underwent contrast-enhanced abdominopelvic CT were retrospectively reviewed and stratified into statin users and statin nonusers. Subgroup analyses comparing high-intensity statins with low- to moderate-intensity statins were conducted within statin users and similar comparisons were performed within statin users stratified based on baseline eGFR.
RESULTS: Overall, CI-AKI events did not occur less in statin users compared with non-statin users (p = 0.342). Within statin users, CI-AKI events did not decrease in high-intensity statin users compared with low- to moderate-intensity statin users (p = 0.355). Moreover, no significant difference in CI-AKI events was found between high-intensity statin users and low- to moderate-intensity statin users even after stratifying the patients with baseline eGFR.
CONCLUSIONS: Collectively, statin was not significantly associated with the risk of CI-AKI events in patients undergoing contrast-enhanced abdominopelvic CT and high-intensity statins did not show significant association with CI-AKI over low- to moderate-intensity statins in the subgroup analysis.
KEY POINTS: • Statin is not associated with risk of CI-AKI events in patients undergoing intravenous administration of contrast-enhanced CT. • CI-AKI incidence among high-intensity statin users was not significantly different from that of low- to moderate-intensity statin users.
引用
- Park JH, Shin HJ, Choi JY, et al. Is there association between statin usage and contrast-associated acute kidney injury after intravenous administration of iodine-based contrast media in enhanced computed tomography? Eur Radiol. 2020. PMID: 32399711. doi:10.1007/s00330-020-06897-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。